Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 331.87 million as of June 13, 2025. Its market cap has decreased by -43.76% in one year.

Market Cap

331.87M

Enterprise Value

357.69M

Revenue

39.84M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.47

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 331.87M, a decrease of -80.12%. That is a compound annual growth rate of -17.67%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	331.87M	-0.89%
Dec 30, 2024	334.83M	-53.79%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	11.53B	63.96%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Swedish Orphan Biovitrum AB	104.14B
Sectra AB	63.77B
Getinge AB	52.04B
Asker Healthcare Group AB	41.27B
Camurus AB	36.56B
Medicover AB	36.46B
AddLife AB	23.98B
Vimian Group AB	22.71B

Market Cap Rankings